Cargando…

Sulforaphane suppresses the activity of sterol regulatory element-binding proteins (SREBPs) by promoting SREBP precursor degradation

Sterol regulatory element-binding proteins (SREBPs) are transcription factors that regulate various genes involved in cholesterol and fatty acid synthesis. In this study, we describe that naturally occurring isothiocyanate sulforaphane (SFaN) impairs fatty acid synthase promoter activity and reduces...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyata, Shingo, Kodaka, Manami, Kikuchi, Akito, Matsunaga, Yuki, Shoji, Kenta, Kuan, Yen-Chou, Iwase, Masamori, Takeda, Keita, Katsuta, Ryo, Ishigami, Ken, Matsumoto, Yu, Suzuki, Tsukasa, Yamamoto, Yuji, Sato, Ryuichiro, Inoue, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130306/
https://www.ncbi.nlm.nih.gov/pubmed/35610278
http://dx.doi.org/10.1038/s41598-022-12347-6
Descripción
Sumario:Sterol regulatory element-binding proteins (SREBPs) are transcription factors that regulate various genes involved in cholesterol and fatty acid synthesis. In this study, we describe that naturally occurring isothiocyanate sulforaphane (SFaN) impairs fatty acid synthase promoter activity and reduces SREBP target gene (e.g., fatty acid synthase and acetyl-CoA carboxylase 1) expression in human hepatoma Huh-7 cells. SFaN reduced SREBP proteins by promoting the degradation of the SREBP precursor. Amino acids 595–784 of SREBP-1a were essential for SFaN-mediated SREBP-1a degradation. We also found that such SREBP-1 degradation occurs independently of the SREBP cleavage-activating protein and the Keap1-Nrf2 pathway. This study identifies SFaN as an SREBP inhibitor and provides evidence that SFaN could have major potential as a pharmaceutical preparation against hepatic steatosis and obesity.